CARES Act and PAMA Impact

In response to the increasing COVID-19 pandemic, the Trump Administration signed the CARES Act into law on March 27, 2020. This act includes new rules and temporary waivers for certain regulations including The Protecting Access to Medicare Act (PAMA). 


Reporting period delayed until 2022

The inclusion of PAMA into the CARES Act has further delayed the reporting period by an additional year. Reporting scheduled to take place between January 1 and March 31, 2021 has been delayed by one year.

The next reporting cycle is now between January 1 and March 31, 2022. However, data collection period remains as January 1 to June 30, 2019. 


How does this affect reimbursement rates?

The CARES Acts freezes current (2020) CMS CLFS rates through 2021, meaning the reduction cap is 0%.  The 15% reduction cap originally planned for 2021-2023 is now delayed to 2022-2024. 


External Resources to Learn More:

American Society for Clinical Pathology

CLMA’s COVID-19 Resource Community (Registration Required) 


Mayo Clinic Laboratories Outreach Team (@mayocliniclaboratoriesoutreachteam)

Mayo Clinic Laboratories Outreach Team